Amplification of platelet-derived growth factor receptor (PDGFR) genes, CDKN2A/2B homozygous deletion, and PI3K (phosphoinositide 3-kinase) mutations have been recently associated with worse prognosis in grade 3 astrocytomas [29]. Here, CDKN2A is linked to astrocytoma (excluding glioblastoma).